You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 616 Pharmacokinetics and safety of a subcutaneous formulation of nivolumab (NIVO SC) monotherapy: updated results from the phase 1/2 CheckMate 8KX study

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial Completed
616 Pharmacokinetics and safety of a subcutaneous formulation of nivolumab (NIVO SC) monotherapy: updated results from the phase 1/2 CheckMate 8KX study

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023412018
Dec 2023141019
Jan 20247609
Feb 202410807
Mar 2024186016
Apr 2024132014
May 2024140010
Jun 2024148025
Jul 2024178010
Aug 2024160022
Sep 2024132011
Oct 2024148024
Nov 2024190026
Dec 2024164027
Jan 2025258044
Feb 202554033
Mar 20250023
Apr 20250027
May 20250050
Jun 20250041
Total26270456